Keyword: Rubius Therapeutics
Allergan CFO Hilado and Gilead COO Young will retire from their positions and Rubius has poached a GSK SVP as CMO.
Carpenter will work as point person on Rubius’ development activities as it gears up to move its CAR-T-rivaling cell therapy into human testing.
Epstein was named executive chairman of Rubius; ex-PTC exec Rothera jumped ship to Orchard; Maverick tapped former Pacira COO Scibetta as CEO.
Rubius Therapeutics has raised $120 million to take two of its off-the-shelf red blood cell therapies into the clinic.